Life
Briefing: Large drugmakers are developing fewer antibiotics, analysis finds
Strategic angle: The number of potential antimicrobial treatments being developed by the world’s largest drugmakers nosedived by 35% over the past five years, according to a new analysis.
editorial-staff
1 min read
Updated about 1 month ago
Summary
- Summary pending editorial review.
Key Facts
| Fact | Value |
|---|---|
| Decline in Development | 35% decrease in potential antimicrobial treatments |
| Timeframe | Over the past five years |